Stocks › CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
CLOV·Nasdaq·
United States·USD
United States·USD$4.60
-0.08 (-1.71%)
Close · Oct 6, 2026 · Close Prices from Tiingo.com
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE · Nasdaq
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
CLOVS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of CLOV by members of U.S. Congress · 0 on record
No congressional trades in CLOV on record.
Whale Activity
Position changes in CLOV reported for 2026-06-30 by 8 tracked institutional filers
- Increased6
- New0
- Held0
- Decreased2
- Closed0
- No prior filing0
| Filer | Shares | Value | Change |
|---|---|---|---|
| BlackRock, Inc. | 35.1M | $184.0M | increased |
| VANGUARD CAPITAL MANAGEMENT LLC | 18.0M | $94.5M | increased |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 4.5M | $23.4M | increased |
| RENAISSANCE TECHNOLOGIES LLC | 2.8M | $14.7M | decreased |
| CITADEL ADVISORS LLC | 2.2M | $11.3M | increased |
| D. E. Shaw & Co., Inc. | 2.0M | $10.3M | increased |
| MILLENNIUM MANAGEMENT LLC | 1.1M | $5.8M | decreased |
| Point72 Asset Management, L.P. | 1.1M | $5.6M | increased |
KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.
Insider Trading
Net shares bought (+) or sold (−) on the open market by CLOV insiders, by quarter · Form 4
Recent Insider Transactions
346 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| Reynoso Jamie L.CEO, Medicare Advantage | Sale | −8,750 | $4.42 | $39K | Oct 5, 2026 | Form 4 ↗ |
| Toy AndrewChief Executive Officer · Director | Sale | −318.8K | $4.19 | $1.3M | Oct 1, 2026 | Form 4 ↗ |
| Reynoso Jamie L.CEO, Medicare Advantage | Sale | −1,921 | $4.56 | $9K | Sep 17, 2026 | Form 4 ↗ |
| OLDAKOWSKI JOSEPH FRANKVP OF FINANCE AND CONTROLLER | Sale | −3,170 | $4.64 | $15K | Sep 16, 2026 | Form 4 ↗ |
| Wai ConradCEO, Counterpart Health | Sale | −300.0K | $4.72 | $1.4M | Sep 15, 2026 | Form 4 ↗ |
| Soares KarenChief Legal Officer | Sale | −6,846 | $4.78 | $33K | Sep 15, 2026 | Form 4 ↗ |
| Reynoso Jamie L.CEO, Medicare Advantage | Sale | −9,273 | $4.78 | $44K | Sep 15, 2026 | Form 4 ↗ |
| OLDAKOWSKI JOSEPH FRANKVP OF FINANCE AND CONTROLLER | Sale | −20.0K | $5.16 | $103K | Sep 14, 2026 | Form 4 ↗ |
| THORNTON JOSEPH CLAYInterim CFO | Sale | −17.8K | $4.39 | $78K | Aug 17, 2026 | Form 4 ↗ |
| Toy AndrewChief Executive Officer · Director | Sale | −87.8K | $4.65 | $408K | Aug 10, 2026 | Form 4 ↗ |
| Soares KarenChief Legal Officer | Sale | −51.7K | $4.51 | $233K | Jul 20, 2026 | Form 4 ↗ |
| Reynoso Jamie L.CEO, Medicare Advantage | Sale | −4,839 | $4.53 | $22K | Jul 17, 2026 | Form 4 ↗ |
| Toy AndrewChief Executive Officer · Director | Sale | −62.7K | $4.67 | $293K | Jul 15, 2026 | Form 4 ↗ |
| Wai ConradCEO, Counterpart Health | Sale | −24.2K | $4.67 | $113K | Jul 15, 2026 | Form 4 ↗ |
| Reynoso Jamie L.CEO, Medicare Advantage | Sale | −13.1K | $4.67 | $61K | Jul 15, 2026 | Form 4 ↗ |
| Soares KarenChief Legal Officer | Sale | −10.5K | $4.67 | $49K | Jul 15, 2026 | Form 4 ↗ |
| THORNTON JOSEPH CLAYInterim CFO | Sale | −4,630 | $4.67 | $22K | Jul 15, 2026 | Form 4 ↗ |
| Reynoso Jamie L.CEO, Medicare Advantage | Sale | −2,384 | $4.68 | $11K | Jul 8, 2026 | Form 4 ↗ |
| Reynoso Jamie L.CEO, Medicare Advantage | Sale | −6,229 | $5.26 | $33K | Jul 6, 2026 | Form 4 ↗ |
| Toy AndrewChief Executive Officer · Director | Sale | −313.5K | $5.32 | $1.7M | Jul 1, 2026 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding CLOV · SEC Form N-PORT
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 13.0M | $68.0M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF iShares Trust | 10.8M | $56.6M | 0.07% | Jun 30, 2026 |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 4.6M | $24.3M | 0.02% | Jun 30, 2026 |
| iShares Russell 2000 Growth ETF iShares Trust | 3.9M | $20.4M | 0.13% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund Fidelity Salem Street Trust | 4.6M | $19.2M | 0.06% | Jul 31, 2026 |
| College Retirement Equities Fund - Total Global Stock Account College Retirement Equities Fund | 1.8M | $9.7M | 0.01% | Jun 30, 2026 |
| VANGUARD RUSSELL 2000 INDEX FUND VANGUARD SCOTTSDALE FUNDS | 2.1M | $8.4M | 0.05% | May 31, 2026 |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 2.1M | $8.2M | 0.02% | May 31, 2026 |
| Schwab U.S. Small-Cap ETF SCHWAB STRATEGIC TRUST | 1.9M | $7.7M | 0.03% | May 31, 2026 |
| Nuveen Quant Small Cap Equity Fund TIAA-CREF Funds | 1.8M | $7.4M | 0.18% | Jul 31, 2026 |
Mutual funds and ETFs whose N-PORT filings list CLOV's shares (CUSIP 18914F103), each fund at its latest report since Mar 7, 2026, largest positions first. Bonds, options and short positions are left out.
Activist & Passive Stakes
Schedule 13D / 13G beneficial-ownership filings
No 13D/13G beneficial-ownership filings on record.
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming CLOVER HEALTH INVESTMENTS, CORP. /DE as client
No lobbying filings found naming CLOVER HEALTH INVESTMENTS, CORP. /DE as the client.
Government Contracts
Federal awards to CLOVER HEALTH INVESTMENTS, CORP. /DE · USAspending
No federal contract awards found for CLOVER HEALTH INVESTMENTS, CORP. /DE.
U.S. Patents
Recent USPTO applications naming CLOVER HEALTH INVESTMENTS, CORP. /DE
No USPTO patent applications found for CLOVER HEALTH INVESTMENTS, CORP. /DE.
Annual Financials
From CLOV's 10-K filings · XBRL
No annual XBRL figures on record for CLOV. KeyVex's fundamentals cover about 130 large companies so far.
Stock Splits
Every split and reverse split in the price history
No stock splits in CLOV's price history.
Material Events (8-K)
Corporate events filed with the SEC
- 8-K/A · Items 5.02, 9.01Officer / director changeSep 25, 2026
EDGAR ↗ - 8-K · Items 5.02, 9.01Officer / director changeSep 24, 2026
EDGAR ↗ - 8-K · Items 7.01, 9.01Reg FD disclosureAug 20, 2026
EDGAR ↗ - 8-K · Items 2.02, 9.01Results of operationsAug 5, 2026
EDGAR ↗ - 8-K · Items 8.01Other eventsJul 17, 2026
EDGAR ↗ - 8-K · Items 8.01Other eventsJun 18, 2026
EDGAR ↗ - 8-K · Items 5.02Officer / director changeJun 16, 2026
EDGAR ↗ - 8-K · Items 5.07Shareholder voteJun 12, 2026
EDGAR ↗ - 8-K · Items 8.01Other eventsJun 10, 2026
EDGAR ↗ - 8-K · Items 7.01, 9.01Reg FD disclosureMay 18, 2026
EDGAR ↗
About CLOVER HEALTH INVESTMENTS, CORP. /DE
From SEC EDGAR company records
Industry (SIC 6324)Hospital & Medical Service Plans
SectorFinancials
HeadquartersJERSEY CITY, NJ
IncorporatedDE
SEC CIK0001801170 ↗
Former namesSocial Capital Hedosophia Holdings Corp. III